atenolol has been researched along with Pre-Eclampsia in 18 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with atenolol reduced the incidence of preeclampsia from 5 of 28 (18%) to 1 of 28 (3." | 6.69 | Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. ( Brateng, D; Brown, Z; Easterling, TR; Millard, SP; Schmucker, B, 1999) |
| "Early treatment of high cardiac output with atenolol decreases the risk for preeclampsia." | 5.35 | Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy. ( Brateng, DA; Carr, DB; Easterling, TR; Karumanchi, SA; Kawamura, C; Shofer, JB; Tran, LT, 2009) |
| " The incidence of severe hypertension was significantly lower when nifedipine (odds ratio, 0." | 5.05 | Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. ( Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V, 2020) |
| "Atenolol taken at the time of conception and/or during the first trimester of pregnancy was associated with low birth weight." | 3.71 | Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester? ( Bayliss, H; Beevers, DG; Beevers, M; Churchill, D, 2002) |
| "Atenolol therapy was not randomized." | 2.70 | The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. ( Brateng, D; Carr, DB; Desai, M; Easterling, TR; McDonald, GB; Thach, CT, 2001) |
| "Treatment with atenolol reduced the incidence of preeclampsia from 5 of 28 (18%) to 1 of 28 (3." | 2.69 | Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. ( Brateng, D; Brown, Z; Easterling, TR; Millard, SP; Schmucker, B, 1999) |
| "Myocardial infarction is rare in pregnancy." | 2.39 | Myocardial infarction in a parturient. A case report with emphasis on medication and management. ( Haring, P; Hietakorpi, S; Koski, E; Nuutinen, LS; Purhonen, S; Söderlin, MK, 1994) |
| "Early treatment of high cardiac output with atenolol decreases the risk for preeclampsia." | 1.35 | Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy. ( Brateng, DA; Carr, DB; Easterling, TR; Karumanchi, SA; Kawamura, C; Shofer, JB; Tran, LT, 2009) |
| "Hyperdynamic patients had less preeclampsia, less severe preeclampsia, fewer deliveries <34 weeks, and fewer neonatal intensive care unit days compared with those requiring a vasodilator." | 1.35 | Outcomes of pregnancies at risk for hypertensive complications managed using impedance cardiography. ( Chaffin, DG; Webb, DG, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bellos, I | 1 |
| Pergialiotis, V | 1 |
| Papapanagiotou, A | 1 |
| Loutradis, D | 1 |
| Daskalakis, G | 1 |
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| Carr, DB | 2 |
| Tran, LT | 1 |
| Brateng, DA | 1 |
| Kawamura, C | 1 |
| Shofer, JB | 1 |
| Karumanchi, SA | 1 |
| Easterling, TR | 3 |
| Chaffin, DG | 1 |
| Webb, DG | 1 |
| Bayliss, H | 2 |
| Churchill, D | 2 |
| Beevers, M | 1 |
| Beevers, DG | 1 |
| Damron, DP | 1 |
| Arxer, A | 1 |
| Pardina, B | 1 |
| Blas, I | 1 |
| Ramió, L | 1 |
| Villalonga, A | 1 |
| Fuerst, M | 1 |
| Söderlin, MK | 1 |
| Purhonen, S | 1 |
| Haring, P | 1 |
| Hietakorpi, S | 1 |
| Koski, E | 1 |
| Nuutinen, LS | 1 |
| Ellis, MR | 1 |
| Kane, KY | 1 |
| Beevers, G | 1 |
| Carbonne, B | 1 |
| Jannet, D | 1 |
| Milliez, J | 1 |
| Brateng, D | 2 |
| Schmucker, B | 1 |
| Brown, Z | 1 |
| Millard, SP | 1 |
| McDonald, GB | 1 |
| Desai, M | 1 |
| Thach, CT | 1 |
| Rollins, G | 1 |
| Lunell, NO | 1 |
| Persson, B | 1 |
| Aragon, G | 1 |
| Fredholm, BB | 1 |
| Aström, H | 1 |
| Blake, S | 1 |
| MacDonald, D | 1 |
| Hanretty, KP | 1 |
| Whittle, MJ | 1 |
| Rubin, PC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Maternal Hemodynamic Monitoring in Women Undergoing Cesarean Section by Use of NICaS Cardiac Impedance[NCT02902068] | 200 participants (Actual) | Observational | 2016-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for atenolol and Pre-Eclampsia
| Article | Year |
|---|---|
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease | 2020 |
Myocardial infarction in a parturient. A case report with emphasis on medication and management.
Topics: Adult; Aspirin; Atenolol; Delivery, Obstetric; Drug Therapy, Combination; Female; Humans; Myocardial | 1994 |
5 trials available for atenolol and Pre-Eclampsia
| Article | Year |
|---|---|
Chronic hypertension in pregnancy.
Topics: Atenolol; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; F | 2002 |
Beta-blockers may have role in preeclampsia.
Topics: Adrenergic beta-Antagonists; Atenolol; Birth Weight; Clinical Trials as Topic; Female; Humans; Hyper | 1982 |
Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Birth Weight; Cardiac Output; Double-Blind Method; Fem | 1999 |
The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia.
Topics: Adult; Antigens, CD; Antihypertensive Agents; Atenolol; Cardiac Output, High; Female; Fibronectins; | 2001 |
The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment.
Topics: Adult; Atenolol; Bendroflumethiazide; Birth Weight; Drug Therapy, Combination; Embryonic and Fetal D | 1991 |
11 other studies available for atenolol and Pre-Eclampsia
| Article | Year |
|---|---|
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiac Output, High; Female; Hemodynamics; Humans; Longit | 2009 |
Outcomes of pregnancies at risk for hypertensive complications managed using impedance cardiography.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiography, Impedance; Female; Hemodynamics; Humans; Inf | 2009 |
Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester?
Topics: Antihypertensive Agents; Atenolol; Embryonic and Fetal Development; Female; Humans; Hypertension; In | 2002 |
Dural sinus thrombosis in a late preeclamptic woman.
Topics: Adult; Anticoagulants; Antihypertensive Agents; Atenolol; Cerebral Veins; Female; Heparin; Humans; M | 2004 |
Atenolol for prevention of preeclampsia.
Topics: Antihypertensive Agents; Atenolol; Birth Weight; Cardiac Output; Double-Blind Method; Female; Humans | 1999 |
Fetal growth restriction.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Female; Fetal Growth Re | 2000 |
Fetal growth restriction.
Topics: Antihypertensive Agents; Atenolol; Bias; Blood Pressure; Clinical Trials as Topic; Female; Fetal Gro | 2000 |
Guidelines on high blood pressure in pregnancy give new classifications of disease.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Contra | 2000 |
Circulatory and metabolic effects of acute beta 1-blockade in severe pre-eclampsia.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; Blood Pressure; Cyclic AMP; | 1979 |
Reappearance of end-diastolic velocity in a pregnancy complicated by severe pregnancy-induced hypertension.
Topics: Adult; Atenolol; Blood Flow Velocity; Diastole; Female; Humans; Hypertension; Pre-Eclampsia; Pregnan | 1988 |